Back
 IJCM  Vol.7 No.9 , September 2016
Retiform Sertoli-Leydig Cell Tumor of the Ovary
Abstract: Sertoli-Leydig cell tumor of the ovary is a kind of sex cord-stromal tumor, which occurs between teens and twenties with symptoms including abdominal pain and swelling. The incidence rate is infinitely rare comprising less than 0.5% of all ovarian tumor. The average age of “retiform Sertoli-Leydig cell tumor” is 17 years as compared to 25 years for Sertoli-Leydig cell tumors as a group. We have experienced this rare case of retiform Sertoli-Leydig cell tumor in a 25-year-old foreign patient with the complaint of palpable mass on the right lower quadrant and an irregular menstrual period. The patient underwent right salpingo-oophorectomy and tumor stage was FIGO stage 1A. We report with a brief review of literature.
Cite this paper: Yu, G. , Choi, S. , Kang, Y. and Park, C. (2016) Retiform Sertoli-Leydig Cell Tumor of the Ovary. International Journal of Clinical Medicine, 7, 592-597. doi: 10.4236/ijcm.2016.79065.
References

[1]   Roth, L.M., Anderson, M.C., Govan, A.D.T., Langley, F.A., Gowing, N.F. and Woodcock, A.S. (1981) Sertoli-Leydig Cell Tumors—A Clinicopathologic Study of 34 Cases. Cancer, 48, 187-197.
http://dx.doi.org/10.1002/1097-0142(19810701)48:1<187::AID-CNCR2820480130>3.0.CO;2-1

[2]   Pick, L. (1905) Ueber Neubildungen am Genitale bei Zwittern nebst Beutraegen zur von den Adenomen des Hodens und Elerstocks. Arch Genaekol, 76, 1912.

[3]   Meyer, R. (1931) Pathology of Some Special Ovarian Tumors and Their Relation to Sex Characteristics. American Journal of Obstetrics & Gynecology, 22, 679-713.
http://dx.doi.org/10.1016/S0002-9378(31)90960-5

[4]   Kanter, A.E. and Klawans, A.H. (1940) Arrhenoblastoma of the Ovary. American Journal of Cancer, 40, 474-484.

[5]   Piver, S.M. (1983) Ovarian Malignancies. Current Reviews in Obstetrics and Gynecology. Churchill Livingstone, New York, 183.

[6]   Russel, P. and Bannatyne, P. (1989) Androblastomas. In: Russell, P. and Bannatyne, P., Eds., Surgical Pathology of the Ovaries, Churchill Livingstone, Edinburgh, New York, 346-365.

[7]   Tavassoli, F.A. and Devilee, P., Eds. (2003) World Health Organization Classfication of Tumors. Pathology & Genetics of Tumours of the Breast and Female Genital Organs. IARC (International Agency for Research on Cancer) Press, Lyon, 153-158.

[8]   Roth, L.M., Slayton, R.E., Brady, L.W., Blessing, J.A. and Johnson, G. (1985) Retiform Differentiation in Ovarian Sertoli-Leydig Cell Tumors: A Clinicopathologic Study of Six Cases from a Gynecologic Oncology Group Study. Cancer, 55, 1093-1098.
http://dx.doi.org/10.1002/1097-0142(19850301)55:5<1093::AID-CNCR2820550526>3.0.CO;2-O

[9]   Young, R.H. and Scully, R.E. (1983) Ovarian Sertoli-Leydig Cell Tumors with Retiform Pattern: A Problem in Histopathologic Diagnosis. A Report of 25 Cases. American Journal of Surgical Pathology, 7, 755-771.
http://dx.doi.org/10.1097/00000478-198307080-00005

[10]   Young, R.H. and Scully, R.E. (1985) Ovarian Sertoli-Leydig Cell Tumors. A Clinico-Pathological Analysis of 207 Cases. American Journal of Surgical Pathology, 9, 543-569.
http://dx.doi.org/10.1097/00000478-198508000-00001

[11]   Mooney, E.E., Nogales, F.F., Bergeron, C. and Tavassoli, F.A. (2002) Retiform Sertoli-Leydig Cell Tumours: Clinical, Morphological and Immunohistochemical Findings. Histopathology, 41, 110-117.
http://dx.doi.org/10.1046/j.1365-2559.2002.01426.x

[12]   Young, R.H. and Scully, R.E. (2002) Sex Cord-Stromal, Steroid Cell and Other Ovarian Tumors. In: Blaustein, A. and Kurman, R.J., Eds., Blaustein’s Pathology of Female Genital Tract, 5th Edition, Springer, New York, 929-939.

[13]   Talerman, A. (1987) Ovarian Sertoli-Leydig Cell Tumor (Androblastoma) with Retiform Pattern. Cancer, 60, 3056-3064.
http://dx.doi.org/10.1002/1097-0142(19871215)60:12<3056::AID-CNCR2820601233>3.0.CO;2-R

[14]   Lou, W., Cao, D., Yang, J., Lina, G. and Shen, K. (2011) Retiform Sertoli-Leydig Cell Tumor of Ovary in a 9-Year-Old Girl: Case Report and Review of the Literature. International Journal of Clinical Oncology, 16, 705-708.
http://dx.doi.org/10.1007/s10147-011-0186-6

[15]   Gershenson, D.M., Morris, M., Burke, T.W., Levenback, C., Matthews, C.M. and Wharton, J.T. (1996) Treatment of Poor-Prognosis sex-Stromal Tumors of the Ovary with the Combination of Bleomycin, Etoposide, and Cisplatin. Obstetrics & Gynecology, 87, 527-531. http://dx.doi.org/10.1016/0029-7844(95)00491-2

 
 
Top